Rafael Kramann
Plenary Session 3 presentation title: “Single cell genomics and spatial transcriptomic technologies to understand kidney disease”
Rafael Kramann, MD, PhD, FASN
Professor of Medicine, Institute of Experimental Medicine and Systems Biology, RWTH Aachen University, Aachen, Germany; Director Laboratory of Translational Kidney and Cardiovascular Research, Erasmus Medical Center, Rotterdam, the Netherlands
Rafael Kramann is Professor of Medicine, Director of the Institute of Experimental Medicine and Systems Biology and Associate Senior Attending Renal Physician at the Department of Nephrology and Clinical Immunology at RWTH Aachen, Germany. He further directs the Laboratory of Translational Kidney and Cardiovascular Research at the Erasmus Medical Center Rotterdam, NL. He received his MD in cardiology at RWTH Aachen University in 2007, postdoctoral training at Brigham and Women’s Hospital, Harvard Medical School, Boston MA and a PhD in internal medicine at Erasmus MC, Rotterdam.
His basic and translational research focusses on understanding chronic kidney disease and fibrotic diseases (www.kramannlab.com). He integrates state of the art genetic fate tracing, gene editing, single cell, multi-omics and systems biology technologies together with clinical datasets to identify novel therapeutic targets and develop targeted therapeutics for patients with CKD.
He has authored more than 100 primary research articles, book chapters and review articles and he is recipient of various prestigious awards including the Grand Prize in the Harvard Innovation Lab Dean´s Health and Lifescience Challenge 2013 the Stanley Shaldon Award of the European Renal Association (ERA-EDTA) 2014, a European Research Council Starting Grant 2015, the Nils Alwall, Carl Ludwig and Franz Volhard Awards 2014, 2015 and 2019 of the German Society of Nephrology, the Bernd Tersteegen Award 2015 of the German Dialysis Association, the Desiderius Award of the Erasmus University in 2018 and the Theodor Frerichs Award of the German Society of Internal Medicine (DGIM) in 2021. He is coordinator of the ERA-CVD NET MEND-AGE consortium and PI at the British Heart Foundation Center of Excellence at the University of Edinburgh, UK where he holds an honorary Professorship.
